Eventually, focused ultrasound treatment of epilepsy might constitute a promising avenue for further exploration. Apart from elucidating the underlying therapeutic mechanisms, it will be important to demonstrate versatility of the approach in different models of epilepsy, including models of pharmacoresistant limbic epilepsy. Key advantages of this technology, such as safety, noninvasiveness, focused application, and accessibility of deeper brain structures, will theoretically permit the treatment of different types of focal epilepsies, and the treatment—being versatile—might be tailored to a patient's needs and combine cost-effectiveness with easy use.
展开▼
